Observational studies of antihypertensive medication use and compliance: Is drug choice a factor in treatment adherence?

被引：47
作者：
Payne K.A. [1 ]
Esmonde-White S. [1 ]
机构：
[1] Caro Research, Dorval, QC H9S 2B6
来源：
Current Hypertension Reports | 2000年 / 2卷 / 6期
关键词：
Calcium Channel Blocker; Angiotensin Converting Enzyme Inhibitor; Antihypertensive Medication; Antihypertensive Therapy; Antihypertensive Prescription;
D O I：
10.1007/s11906-996-0035-6
中图分类号：
学科分类号：
摘要：
Real-world adherence to pharmacotherapy cannot be studied in the confines of the traditional clinical trial. Thus, to better understand adherence to antihypertensive medication in actual practice, a literature search was conducted to identify observational database studies of the use of antihypertensive medication. Ten studies were identified: half studied adherence patterns after initial prescriptions to patients with a new diagnosis of hypertension, and the others evaluated antihypertensive medication use in a mix of patients with newly diagnosed or chronic hypertension. Overall, results demonstrated that adherence to treatment for hypertension in the first year is very poor. In addition, it appears that initial treatment with newer classes of drugs, such as angiotensin II antagonists, angiotensin converting enzyme inhibitors, and calcium channel blockers favors treatment adherence. This review also highlights and discusses possible underlying factors contributing to these results and implications for physicians. Copyright © 2000 by Current Science Inc.
引用
收藏
页码：515 / 524
页数：9
相关论文
共 56 条
  • [1] Semenciw R.M., Morrison H.I., Mao Y., Et al., Major risk factors for cardiovascular disease mortality in adults: Results from the Nutrition Canada Survey Cohort, Int J Epidemiol, 17, pp. 317-324, (1988)
  • [2] Rabkin S.W., Matthewson F.A.L., Tate R.B., Predicting risk of ischemic heart disease and cerebrovascular disease from systolic and diastolic blood pressure, Ann Intern Med, 88, pp. 342-345, (1978)
  • [3] Heart and Stroke Facts, (1994)
  • [4] Chan B., Coyte P., Heick D., Economic impact of cardiovascular disease in Canada, Can J Cardiol, 12, pp. 1000-1006, (1996)
  • [5] Burt V.L., Whelton P., Roccella E.J., Et al., Prevalence of hypertension in the US adult population: Results from the Third National Health and Nutrition Examination Survey, 1988-1991, Hypertension, 25, pp. 305-313, (1995)
  • [6] Stockwell D.M., Madhaven S., Cohen H., Et al., The determinants of hypertension, awareness, treatment and control in an insured population, Am J Public Health, 84, pp. 1768-1774, (1994)
  • [7] Hershey J.C., Morton B.G., Davis J.B., Et al., Patient compliance with antihypertensive medication, Am J Public Health, 70, pp. 1081-1089, (1980)
  • [8] Lucher T.F., Vetter H., Siegenthaler W., Et al., Compliance in hypertension: Facts and concepts, J Hypertens, 3, pp. 3-9, (1985)
  • [9] Bittar N., Maintaining long-term control of blood pressure: The role of improved compliance, Clin Cardiol, 18, pp. 312-316, (1995)
  • [10] Clark T., Improving patient compliance and increasing control of hypertension: Needs of special hypertensive populations, Am Heart J, 121, PART 2, pp. 664-669, (1991)
123456